MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by REMMER, H.
Right arrow Articles by ROSENTHAL, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by REMMER, H.
Right arrow Articles by ROSENTHAL, O.

Molecular Pharmacology, Vol 2, 187-190, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics

Drug Interaction with Hepatic Microsomal Cytochrome

H. REMMER 1, J. SCHENKMAN 1, R. W. ESTABROOK 1, H. SASAME 2, J. GILLETTE 2, S. NARASIMHULU 3, D. Y. COOPER 3, and O. ROSENTHAL 3

1 Johnson Research Foundation, University of Pennsylvania, Philadelphia, Pennsylvania
2 Laboratory of Chemical Pharmacology, National Institutes of Health, Bethesda, Maryland
3 Harrison Department of Surgical Research, University of Pennsylvania

The addition to liver microsomes of various substrates, such as hexobarbital, aminopyrine, or aniline, causes two types of spectral changes. Spectrophotometric studies suggest that these changes are related to substrate interaction with a microsomal hemoprotein. On the basis of these observations, two hypotheses are suggested to explain the interaction of substrates with the liver microsomal mixed function oxidase system.

Note:
This work was supported in part by a grant from the National Science Foundation (GB 2451) and grants (AM 07217, AM 04484, and GM 12202) of the U. S. Public Health Service. The studies were carried out during tenures of U.S.P.H.S. Research Career Development Awards HE 25132 to D. Y. Cooper and GM-K3-4111 to R. W. Estabrook.

Submitted on November 22, 1965




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
P. J. Murphy
The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 2, 1959-1983
Drug Metab. Dispos., June 1, 2008; 36(6): 981 - 985.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. M. Miller, J. Cai, S. L. Ripp, W. M. Pierce Jr., T. H. Rushmore, and R. A. Prough
STEREO- AND REGIOSELECTIVITY ACCOUNT FOR THE DIVERSITY OF DEHYDROEPIANDROSTERONE (DHEA) METABOLITES PRODUCED BY LIVER MICROSOMAL CYTOCHROMES P450
Drug Metab. Dispos., March 1, 2004; 32(3): 305 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Zhong, X. Li, S. Yamashina, M. von Frankenberg, N. Enomoto, K. Ikejima, M. Kolinsky, J. A. Raleigh, and R. G. Thurman
Cyclosporin A Causes a Hypermetabolic State and Hypoxia in the Liver: Prevention by Dietary Glycine
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Qu, L. M. Graves, and R. G. Thurman
PGE2 stimulates O2 uptake in hepatic parenchymal cells: involvement of the cAMP-dependent protein kinase
Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1048 - G1054.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Zhong, H. Connor, R. F. Stachlewitz, M. v. Frankenberg, R. P. Mason, J. J. Lemasters, and R. G. Thurman
Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
Mol. Pharmacol., November 1, 1997; 52(5): 912 - 919.
[Abstract] [Full Text]


Home page
ScienceHome page
D. W. Shoeman, J. G. White, and G. J. Mannering
Cytochrome P-420: Tubular Aggregates from Hepatic Microsomes
Science, September 26, 1969; 165(3900): 1371 - 1372.
[Abstract] [PDF]


Home page
ScienceHome page
C. J. Sih
Enzymatic Mechanism of Steroid Hydroxylation
Science, March 21, 1969; 163(3873): 1297 - 1300.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics